How Akt Affects Apoptosis in Ovarian Cancer Cells Treated with Cisplatin
Author Information
Author(s): Yang X, Fraser M, Abedini M R, Bai T, Tsang B K
Primary Institution: University of Ottawa
Hypothesis
The study investigates the role of Akt in regulating cisplatin-induced apoptosis in ovarian cancer cells, particularly focusing on the mitochondrial apoptosis-inducing factor (AIF).
Conclusion
The study concludes that Akt activation inhibits cisplatin-induced apoptosis by blocking the mitochondrial release and nuclear translocation of AIF, contributing to chemoresistance in ovarian cancer cells.
Supporting Evidence
- Cisplatin induces mitochondrial AIF translocation and apoptosis in chemosensitive ovarian cancer cells.
- Overexpression of AIF sensitized resistant cells to cisplatin-induced apoptosis.
- Akt activation attenuates cisplatin-induced mitochondrial release and nuclear accumulation of AIF.
- Downregulation of AIF conferred resistance to chemosensitive cells.
- Modulation of Akt activity may represent a novel therapeutic approach to treat cisplatin-resistant ovarian cancer.
Takeaway
This study shows that a protein called Akt can stop cancer cells from dying when treated with a drug called cisplatin, which is supposed to kill them. If we can block Akt, it might help the drug work better.
Methodology
The study used chemosensitive and chemoresistant ovarian cancer cell lines treated with cisplatin, followed by assessments of AIF levels and apoptosis through western blotting and Hoechst staining.
Potential Biases
Potential bias may arise from the use of specific cell lines that may not represent all ovarian cancer types.
Limitations
The study primarily focuses on in vitro experiments, which may not fully replicate in vivo conditions.
Participant Demographics
The study involved human ovarian cancer cell lines, specifically chemosensitive (OV2008, A2780s) and chemoresistant (C13*, A2780cp) variants.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website